Bottom line
GVALX vs MNDFX: the short answer
GVALX (Gotham Large Value Fund) and MNDFX (Disciplined Value Series) are quite different portfolios: only about 31% of their top holdings (by weight) are shared.
But GVALX is far broader, holding 275 positions to 127 for MNDFX, so beyond the top names it adds exposure MNDFX doesn't have.
MNDFX is cheaper at 0.57% vs 0.75% — a difference of $18 a year per $10,000 invested.
Over five years, GVALX returned +11.4% a year vs +9.9% for MNDFX.
Updated Nov 19, 2026
GVALX vs MNDFX side by side
| GVALX | MNDFX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fundvantage | Manning & Napier |
| Category | Large Value | Large Value |
| Expense ratio | 0.75% | 0.57% |
| Annual cost per $10k | $75 | $57 |
| 10-yr cost on $10k (prospectus) | $1,404 | $713 |
| Max front load | — | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +13.9% | +15.9% |
| 5-yr return (annualized) | +11.4% | +9.9% |
| 10-yr return (annualized) | +11.7% | +10.8% |
| Best quarter | +18.3% | +15.2% |
| Worst quarter | −26.1% | −25.1% |
| Net assets (fund) | $31.6M | $130.8M |
| Number of holdings | 275 | 127 |
| Portfolio turnover | 2% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | GVALX | MNDFX | Difference |
|---|---|---|---|
| 2025 | +13.9% | +15.9% | −2.0% |
| 2024 | +12.2% | +11.7% | +0.5% |
| 2023 | +11.8% | +5.5% | +6.2% |
| 2022 | −6.8% | −4.3% | −2.6% |
| 2021 | +29.0% | +22.5% | +6.5% |
| 2020 | +3.4% | +2.5% | +0.9% |
| 2019 | +29.0% | +24.3% | +4.7% |
| 2018 | −4.6% | −4.1% | −0.5% |
| 2017 | +22.2% | +23.1% | −0.9% |
| 2016 | +12.9% | +15.5% | −2.6% |
Source: Fund prospectus bar charts
Holdings overlap
8 of GVALX's top 25 holdings also appear in MNDFX's top 25.
| Holding | GVALX | MNDFX |
|---|---|---|
| Merck & Company Inc | 1.54% | 3.83% |
| Qualcomm Inc | 1.32% | 1.97% |
| Pfizer Inc | 1.31% | 1.77% |
| Bristol-myers Squibb Company | 1.15% | 2.25% |
| Citigroup Inc | 1.09% | 3.48% |
| Gilead Sciences Inc | 1.05% | 2.50% |
| Unitedhealth Group Inc | 1.00% | 2.79% |
| Conocophillips | 0.93% | 2.37% |
Source: SEC Form N-PORT
GVALX top 10
- Lam Research Corp — 2.70%
- Caterpillar Inc — 1.72%
- Merck & Company Inc — 1.54%
- Coca-cola Company (the) — 1.32%
- Qualcomm Inc — 1.32%
- Pfizer Inc — 1.31%
- Altria Group Inc — 1.21%
- Bristol-myers Squibb Company — 1.15%
- Pepsico Inc — 1.10%
- Citigroup Inc — 1.09%
MNDFX top 10
- Merck & Company Inc — 3.83%
- Citigroup Inc — 3.48%
- Unitedhealth Group Inc — 2.79%
- Wells Fargo & Company — 2.55%
- Gilead Sciences Inc — 2.50%
- Conocophillips — 2.37%
- Bristol-myers Squibb Company — 2.25%
- Exxonmobil Holdings Corp — 2.01%
- Qualcomm Inc — 1.97%
- US Bancorp — 1.87%
FAQ
What is the difference between GVALX and MNDFX?
Which is cheaper, GVALX or MNDFX?
Should I own both GVALX and MNDFX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.